Lombard inks stem cell-coated stent deal
This article was originally published in Clinica
Executive Summary
Signalling a new era in coronary stents, UK firms Lombard Medical Technologies and Axordia are forging an alliance to develop a regenerative stent that will incorporate into a polymer coating the healing properties of stem cells.